Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
This study is about testing a new treatment called SBT777101 for people with rheumatoid arthritis (RA), which is a disease that causes painful swelling in the joints. This treatment uses a special type of cell from your own body, called Treg cells, to help reduce inflammation and make your immune system healthier. The study gives the treatment in one dose, starting with small amounts to make sure it's safe before trying larger doses.
- Participants must have moderate-to-severe RA and meet certain health criteria.
- You can't join if you've had recent major surgery or certain health conditions.
- Involves a single dose treatment and requires follow-up visits to check safety and effects.
If you’re interested and meet the criteria, this study could offer a new way to manage your RA. Talk to your doctor to see if it's right for you. 😊
Study details
NCT06201416
Sonoma Biotherapeutics, Inc.
24 January 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.